HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Methylprednisolone Hemisuccinate (A-MethaPred)

A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.
Also Known As:
A-MethaPred; Methylprednisolone Succinate; 6 alpha-Methylprednisolone Sodium Hemisuccinate; Methylprednisolone Hemisuccinate Monosodium Salt; Methylprednisolone Sodium Hemisuccinate; Methylprednisolone Sodium Succinate; Solu-Medrol; Solumedrol; Urbason-Soluble; Hemisuccinate, Methylprednisolone; Sodium Hemisuccinate, Methylprednisolone; Sodium Succinate, Methylprednisolone; Succinate, Methylprednisolone; UrbasonSoluble; Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
Networked: 258 relevant articles (21 outcomes, 48 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Okutan, Ozerk: 4 articles (04/2007 - 04/2004)
2. Beskonakli, Etem: 4 articles (04/2007 - 04/2004)
3. Kilinc, Kamer: 3 articles (04/2007 - 01/2005)
4. Nahum, Amit: 2 articles (07/2014 - 05/2009)
5. Marcus, Nufar: 2 articles (07/2014 - 05/2009)
6. Levy, Yael: 2 articles (07/2014 - 05/2009)
7. Wang, Haibo: 2 articles (01/2014 - 11/2013)
8. Zhang, Daogong: 2 articles (01/2014 - 11/2013)
9. Gok, Beril: 2 articles (04/2007 - 04/2007)
10. Kaptanoglu, Erkan: 2 articles (01/2005 - 04/2004)

Related Diseases

1. Pain (Aches)
2. Hypothermia
3. Hemorrhage
4. Spinal Cord Injuries (Spinal Cord Injury)
03/01/1995 - "A model simulating acute-compressive spinal cord trauma at the second lumbar spinal cord segment (100 g, 300 seconds) was used to evaluate the efficacy of a vehicle control, methylprednisolone sodium succinate (MPSS), and a 21-aminosteroid compound (U74389G). "
11/01/2009 - "Currently, methylprednisolone sodium succinate (MPSS) is the standard treatment following acute spinal cord injury (SCI) as a consequence of the results obtained from the National Acute Spinal Cord Injury Studies. "
05/01/2009 - "The use of methylprednisolone sodium succinate (MPSS) in the treatment of traumatic spinal cord injury was initially reported to enhance recovery in the National Acute Spinal Cord Injury Studies (NASCIS), 1990 and 1997. "
01/01/2008 - "Although the primary outcomes in these trials were laregely negative, a secondary analysis of the North American Spinal Cord Injury Study II demonstrated that when administered within 8 hours of injury, methylprednisolone sodium succinate was associated with modest clinical benefits, which need to be weighed against potential complications. "
01/01/2004 - "The publication of the first National Acute Spinal Cord Injury (NASCIS) trial in 1984 ushered in the era of pharmacological trials of therapies intended to improve neurologic outcome in acute SCI. Subsequent trials of methylprednisolone sodium succinate (MPSS) and GM-1 have added to the evidence basis that informs the current management practices for acute SCI. The last 50 years have seen a conceptual shift from the pessimism of the past to a cautious optimism that the meager prognosis for neurologic recovery in acute SCI will yield to the progress of medical science. "
5. Myocardial Infarction

Related Drugs and Biologics

1. Cytarabine (Cytosar-U)
2. Methylprednisolone Hemisuccinate (A-MethaPred)
3. Etoposide (VP 16)
4. Methylprednisolone
5. Cisplatin (Platino)
6. Platinum
7. gemcitabine
8. Prednisolone (Predate)
9. Antineutrophil Cytoplasmic Antibodies (ANCA)
10. Granisetron (Kytril)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Cardiopulmonary Bypass (Heart-Lung Bypass)
3. Autologous Transplantation
4. Spinal Fusion (Spondylosyndesis)
5. Aftercare (After-Treatment)